A Global Life Sciences company was launching a new drug within the US Oncology Market and did not have a formal team and/or strategic launch plan in place one year prior to anticipated FDA approval.
Our Life Sciences client was planning to launch its first Alzheimer’s therapy. Despite being many months away from launch, our client wanted to establish itself as a trusted source of Alzheimer's Disease information, both online and at HCP conferences.
A Blues plan was looking to create a best in class analytics solution available to providers and health systems within their network. The goal was to enable providers to better manage their member populations and drive performance within Value-Based arrangements.
A Global Life Sciences company was launching a new drug within the US Oncology Market and did not have a formal team and/or strategic launch plan in place one year prior to anticipated FDA approval.
Vynamic mapped the internal organization across functions and roles into a RACI with senior management buy-in. Then a draft Transition Framework was developed, followed by validation at several organizational levels and a beta test.
Vynamic conducted a gap analysis of the client’s target markets and competitor engagement strategies, assimilating market research insights and a landscape analysis to identify trends and gaps. Input from local affiliates were incorporated into the research to validate the findings.
Vynamic conducted in-depth benchmarking interviews with Medical Affairs executives from eight top-tier pharmaceutical companies across the industry, offering a summary report in return for participation.
Vynamic interviewed Global, Regional, and Affiliates in order to identify critical drivers, barriers, and attitudes towards lifecycle management. Vynamic then facilitated a workshop to assess strategic options and map high-level readiness plans with positioning, timelines, resources, and KPIs. Vynamic also prioritized country-specific and global-level activities to distinguish the brand using a proprietary diagnostic tool.
Vynamic conducted in-depth surveys to identify institutional, attitudinal, and functional preferences to enable multiple potential segmentation approaches. To identify the optimal segmentation solution, Vynamic implemented sophisticated statistical analysis and data analysis techniques. With the solution identified, an internal workshop was conducted to articulate the differentiated messaging, campaign theme, and brand.
Vynamic partnered with client core team representatives from Field Medical, Global Medical Affairs, and Global Clinical to first identify all stakeholders, single points of contact, and any gaps in the current operating model. All existing and new thought-driven information was synthesized into an Operating Model Framework Tool, which Vynamic designed to encompass the client’s functions, people, processes, and tools. The Operating Model was then communicated throughout the company which Vynamic supported and developed.
Contact our team to learn more about how we can help your needs.
